New program helps lung cancer patients kick the habit

NCT ID NCT02816697

Completed Disease control Sponsor: Dana-Farber Cancer Institute Source: ClinicalTrials.gov ↗

First seen Jun 24, 2026 · Last updated Jun 27, 2026 · Updated 2 times

Summary

This study tested a program called CEASE that helps lung cancer patients quit smoking. The program was built into regular doctor visits and included screening, counseling, and referrals. Researchers studied 263 patients to see if the program improved quit rates and how well it worked in a hospital setting.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: CEASE program (screening, counseling, and referral for smoking cessation)
What this could lead to: If successful, this approach could help more lung cancer patients quit smoking, improving treatment outcomes and quality of life.
What could go wrong: This is an implementation study, not a test of a new drug. Results may vary across hospitals, and quitting smoking is difficult even with support.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for LUNG CANCER are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

lung cancer lung neoplasm Smoking Smoking Cessation thoracic cancer

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

LUNG CANCER SMOKING CESSATION

Contacts and locations

Locations

Brigham and Women's Hospital

Boston, Massachusetts, 02115, United States
Dana Farber Cancer Institute

Boston, Massachusetts, 02115, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.